Video
2023 AUA preview: Dr. Laudano on top research in overactive bladder/incontinence
Author(s):
Melissa A. Laudano, MD, highlights 3 studies in overactive bladder/incontinence being presented at the 2023 American Urological Association Annual Meeting.
In this video, Melissa A. Laudano, MD, discusses 3 studies in overactive bladder/incontinence being presented at the 2023 American Urological Association Annual Meeting in Chicago, Illinois. Laudano is an assistant professor of urology at Montefiore Medical Center and Albert Einstein College of Medicine, Bronx, New York.
The following abstracts were previewed:
1. LBA01-05 (Heesakkers et al):Pivotal study of a novel wirelessly powered, patient tailored programmed, tibial neurostimulator for the treatment of patients with overactive bladder
2. LBA01-18 (Wada et al): Comparison of mirabegron and vibegron for clinical efficacy and safety in female patients with overactive bladder: a multicenter, prospective randomized crossover trial
3. LBA01-19 (Peters et al): Long-term efficacy and safety of URO-902 (PVAX/HSLO) in women with overactive bladder and urge urinary incontinence: final results of a phase 2a trial
